Lipocine appoints Michael J. Grissinger to Board of Directors
Lipocine Inc. announced the appointment of former Johnson & Johnson executive and biotech director Michael J. Grissinger, effective August 3, 2026. This strategic addition strengthens the company’s corporate development and dealmaking capabilities to advance its pipeline.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day